Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Status: | Recruiting |
---|---|
Conditions: | Cancer, Cancer, Brain Cancer, Gastrointestinal, Pancreatic Cancer |
Therapuetic Areas: | Gastroenterology, Oncology |
Healthy: | No |
Age Range: | 18 - 120 |
Updated: | 10/20/2018 |
Start Date: | October 2000 |
End Date: | September 2022 |
Contact: | Cindy Beinhorn |
Email: | pancreas@mayo.edu |
Phone: | 1-800-914-7962 |
Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease
RATIONALE: Gathering medical information and collecting and storing samples of blood and
tissue to test in the laboratory may help doctors develop better ways to screen people at
risk for pancreatic cancer or other pancreatic disorders in the future.
PURPOSE: This clinical trial is collecting medical information and tissue samples from
patients with pancreatic cancer or other pancreatic disorders.
tissue to test in the laboratory may help doctors develop better ways to screen people at
risk for pancreatic cancer or other pancreatic disorders in the future.
PURPOSE: This clinical trial is collecting medical information and tissue samples from
patients with pancreatic cancer or other pancreatic disorders.
OBJECTIVES:
Primary
- To collect clinical data and family histories and blood and/or tissue samples from
patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in
future studies.
- To collect information regarding food preparation and intake in these patients.
Secondary
- To make available to researchers medical data and biospecimens to enable them to develop
better ways to screen people at risk for pancreatic conditions, including pancreatic
cancer.
- To investigate genes or substances that increase susceptibility of developing pancreatic
conditions.
- To find agents that may help prevent, treat, or cure these conditions.
- To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic
cancer, or other cancers.
OUTLINE: This is a multicenter study.
Patients complete two 1-hour surveys assessing health, clinical and family history of
pancreatic conditions including cancer, and food preparation and intake. Patients also
complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health
practices, and family history. A review of the patient's medical information is obtained from
the medical record.
Blood samples are collected for future research studies. Oral cells and stool samples may
also be collected for future studies.
Primary
- To collect clinical data and family histories and blood and/or tissue samples from
patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in
future studies.
- To collect information regarding food preparation and intake in these patients.
Secondary
- To make available to researchers medical data and biospecimens to enable them to develop
better ways to screen people at risk for pancreatic conditions, including pancreatic
cancer.
- To investigate genes or substances that increase susceptibility of developing pancreatic
conditions.
- To find agents that may help prevent, treat, or cure these conditions.
- To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic
cancer, or other cancers.
OUTLINE: This is a multicenter study.
Patients complete two 1-hour surveys assessing health, clinical and family history of
pancreatic conditions including cancer, and food preparation and intake. Patients also
complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health
practices, and family history. A review of the patient's medical information is obtained from
the medical record.
Blood samples are collected for future research studies. Oral cells and stool samples may
also be collected for future studies.
DISEASE CHARACTERISTICS:
- Diagnosis or suspicion of at least one of the following:
- Pancreatic cancer
- Pancreatic mass
- Islet cell tumor
- Intraductal papillary mucinous neoplasms (IPMN)
- Hereditary pancreatitis
PATIENT CHARACTERISTICS:
- Able to understand and read English
- Mentally competent and able to provide informed consent
- Has not donated blood within the past 8 weeks
PRIOR CONCURRENT THERAPY:
- At least 7 days since prior blood transfusion
- At least 7 days since prior surgery
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
Rochester, Minnesota 55905
507-284-2511
Phone: 507-538-7623
Mayo Clinic Cancer Center The Mayo Clinic Cancer Center is a National Cancer Institute-designated comprehensive...
Click here to add this to my saved trials